/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-04-19-08-44-11-740-625e765bf636e9109c05941e.jpg)
The annual report "Indicators of Access to Innovative Therapies in Europe (W.A.I.T. Indicator)", prepared by the consultancy firm Iqvia...
Cortex - Life Sciences Insights
The final session at BIG was entitled Turning Pharma on its Head: The Next Big Thing. There was discussion of particular technologies...
Fascinating and inspiring presentations at BIG about the brain-gut axis and the key role of all mucosal immune systems in CNS related...
I am really looking forward to attending this conference; not just because it is in Aruba!. There is very exciting science happening on...
Between 9 and 11 April I will be in Basilea with Johan Renes from DLA Piper Amsterdam and Paula Gonzalez from DLA Piper Madrid at the...
A Brexit transition period to 31 December 2020 is good news for the Life Sciences industry. Brexit negotiators have now agreed Article...
We have been looking closely at the EMA requirements for publishing clinical data under Policy 0070. There is an expanding body of...
Really looking forward to meeting you at the IP Forum for Life Sciences in April. I will be hosting a discussion with tregard to naming...
Tomorrow I will be on stage at 11 am discussing 'Growing Global' at the Northern Powerhouse Health Innovation Conference 2018. The first...
The most likely explanation for the anomalies identified in the gender pay reports published so far is the fact that, whilst...
At a time when organisations are looking to put their houses in order to address the demands of GDPR, this poses a salutary warning to...
New guidance just out from FDA on its approach to the regulation of digital health. For companies pursuing opportunities where...
This is intriguing and may be the 3D-printer of the life science industry. Obviously, there are many legal pitfalls that require careful...
PD-L1 and checkpoint inhibitors have been front and center in the media relating to the treatment of cancer. Researches are now looking...
Researchers from Harvard identified a new protein, Nrf1, which regulates high cholesterol by binding directly to it. This binding prompts...
We have been hearing for a decade about the use of stem cells to create organs and treat diseases. Today, a study showing that hES cells...
